Browsing eNauka

Browsing by Project Octapharma

Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)TypeМp-cat.
2024Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders DatabaseMohsenian, Samin; ...; Mikovic, Danijela; Saracevic, Marko; ...; (broj, koautora 40)Article
21aM21a
2024Design of an international, phase IV, open-label study of simoctocog alfa in women/girls with hemophilia A undergoing surgery (NuDIMENSION)Marquardt, Natascha; ...; Miljic, Predrag S; ...; (broj, koautora 16)Article
21M21
2016Evaluation of the adequacy of requests for electrodiagnostic examination in a tertiary referral centerNikolić, Ana ; Stević, Zorica ; Perić, Stojan  ; Rakočević-Stojanović, Vidosava ; Lavrnić, Dragana Article
22M22
2012Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practiceBenson, Gary; Auerswald, Guenter; Elezovic, Ivo V; Lambert, Thierry; Ljung, Rolf; Morfini, Massimo; Remor, Eduardo; Zupancic-Salek, SilvaArticle
22M22
2025NuPOWER (Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis): protocol for an open-label, single-arm, multicentre studySrivastava, Alok; ...; Miljic, Predrag; ...; (broj, koautora 20)Article
21M21
2016Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)Palla, Roberta; ...; Mikovic, Danijela; Saracevic, Marko; ...; (broj, koautora 34)Conference Paper
Mp. category will be shown later
2014Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiencyJames, Paula; Salomon, O; Mikovic, Danijela; Peyvandi, FArticle
22M22
2012Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia AAntovic, Jovan P; Mikovic, Danijela; Elezovic, Ivo V; Holmstrom, Margareta; Wilkens, Matthias; Elfvinge, Petra; Soutari, Nida Mahmoud Hourani; Antovic, Aleksandra RArticle
21aM21a
2018Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2Tiede, Andreas; Janic, Dragana M  ; Ozelo, M; Santagostino, E; Korsholm, Lars; Matytsina, Irina; Lentz, SRConference Paper
Mp. category will be shown later